(Q39636826)

13 September 2017

Prevalence and characteristics of early-onset type 2 diabetes in Mexico (English)

1 reference

13 September 2017

0 references

Carlos A Aguilar-Salinas

1

1 reference

13 September 2017

Rosalba Rojas

2

1 reference

13 September 2017

Francisco J Gómez-Pérez

3

1 reference

13 September 2017

Eduardo García

4

1 reference

13 September 2017

Victoria Valles

5

1 reference

13 September 2017

Juan Manuel Ríos-Torres

6

1 reference

13 September 2017

Aurora Franco

7

1 reference

13 September 2017

Gustavo Olaiz

8

1 reference

13 September 2017

Jaime Sepúlveda

9

1 reference

13 September 2017

Juan A Rull

10

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

American Journal of Medicine

13 September 2017

1 reference

13 September 2017

113

1 reference

13 September 2017

569-574

1 reference

13 September 2017

7

1 reference

Early presentation of type 2 diabetes in Mexican-American youth

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Molecular Genetics of Maturity-onset Diabetes of the Young

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Maturity-onset diabetes of youth in black Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Familial hyperglycemia due to mutations in glucokinase. Definition of a subtype of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Emerging epidemic of type 2 diabetes in youth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Incidence of insulin-dependent diabetes (IDDM) and non-insulin-dependent diabetes (NIDDM) (0-34 years at onset) in Benghazi, Libya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Metabolic and immunologic features of Chinese patients with atypical diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Are trends in diabetes incidence changing for minority children?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Non-insulin dependent diabetes mellitus in African-American youths of Arkansas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

High prevalence of diabetes and impaired glucose tolerance in India: National Urban Diabetes Survey.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Prevalence of diabetes among Native Americans and Alaska Natives, 1990-1997: an increasing burden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Chronic diabetic complications in patients with MODY3 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Analysis of the glucokinase gene in Mexican families displaying early-onset non-insulin-dependent diabetes mellitus including MODY families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Insulin-sensitive and insulin-resistant variants in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Patterns of glucose and lipid abnormalities in black NIDDM subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Does intra-abdominal adipose tissue in black men determine whether NIDDM is insulin-resistant or insulin-sensitive?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Different aetiologies of type 2 (non-insulin-dependent) diabetes mellitus in obese and non-obese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Heterogeneous relationship of early insulin response and fasting insulin level with development of non-insulin-dependent diabetes mellitus in non-diabetic Japanese subjects with or without obesity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

MONOGENIC DIABETES MELLITUS IN YOUTH

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901314-1

10.1016/S0002-9343(02)01314-1

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference